The invention discloses a Chinese medicinal composition for the immunoregulation of 
chronic hepatitis B in an 
inactive phase or a 
carrier state. The Chinese medicinal composition consists of the following medicaments in part by weight: 15 to 30 parts of 
astragalus, 10 to 15 parts of largehead atractylodes 
rhizome, 10 to 15 parts of 
epimedium herb, 10 to 15 parts of glossy 
privet fruit, 10 to 15 parts of south dodder seed, 10 to 15 parts of Chinese magnoliavine fruit, 10 to 15 parts of medlar, 15 to 30 parts of red sage root, 15 to 30 parts of 
turtle shell, 15 to 60 parts of underleaf pearl, 10 to 15 parts of buffalo horn, and 10 to 30 parts of Chinese honeylocust spine. The Chinese medicinal composition is applicable to the immunoregulation therapy of the CHB in the 
inactive phase or a low (non) replicative phase and the 
carrier state, is expected to mainly strengthen 
body resistance and also clear residual pathogenic factors, has the effects of replenishing qi, tonifying 
kidney, dissolving 
blood stasis and releasing 
toxin, and can well consolidate and maintain the 
treatment effect of clinical inactive CHB patients and HBV (
hepatitis B 
virus) carriers in an immune tolerant phase and an immune 
active phase of CHB .